News | February 22, 2010

Merge Healthcare Makes New Offer to Purchase AMICAS

February 22, 2010 – RIS/PACS maker Merge Healthcare Inc. said today it is making a bid to purchased the PACS company AMICAS. However, Amicas says it already entered into a merger deal with another company.

It its sixth proposal to purchased AMICAS, Merge said it has a pending $6.05 cash per share offer for AMICAS, totaling about $248 million. This represents a 13 percent premium to the previously announced offer for AMICAS from a newly formed affiliate of Thoma Bravo LLC for $5.35 cash per share.

In amended proxy materials filed today with the Securities and Exchange Commission, Amicas disclosed it received an unsolicited proposal from Merge Healthcare. Merge's highly-conditional proposal is dependent on third-party financing, subject to a "reverse break" fee, which essentially gives Merge a $10 million option to buy AMICAS; subject to a number of additional conditions, the satisfaction of which are within Merge's control, and has been characterized as Merge's "best and final" proposal. Given the highly conditional nature of Merge's most recent proposal, the AMICAS Board of Directors believes that the Merge proposal is illusory and risky to AMICAS stockholders. AMICAS said the Merge deal would also require it to terminate the Thoma Bravo merger and pay the break-up fee of $8.6 million, which AMICAS doubts it would recover from any deal with Merge.

As previously announced on Dec. 24, AMICAS entered into a definitive merger agreement with Thoma Bravo LLC, under which an affiliate of Thoma Bravo would acquire all of the outstanding shares of AMICAS for $5.35 per share in cash. This purchase price is fully financed and guaranteed by Thoma Bravo and other first tier private equity funds and is not dependent on unguaranteed, third-party financing. AMICAS said Thoma Bravo was ready, willing and able to close the transaction on its originally scheduled closing date of Feb. 19, 2010. AMICAS said the Thoma Bravo merger provides AMICAS stockholders with immediate and certain cash value. AMICAS is confident that the Thoma Bravo Merger can be completed in a timely manner immediately following stockholder approval at the special meeting of stockholders scheduled March 4.

AMICAS said it has been advised Thoma Bravo remains fully committed to the transaction.

The AMICAS board and management team actively engaged with Merge and its advisors in an attempt to negotiate a transaction that is in the best interest of AMICAS' stockholders. But after carefully reviewing Merge's most recent proposal, the AMICAS board, consulting with its independent financial and legal advisors, determined the proposal is not a in the best interests of the company. The company said Merge failed to provide sufficient financial guarantees and reasonable protections for AMICAS stockholders.

Merge’s current offer follows its offer of $6 cash per share. The offer was made during the 45-day "go-shop" period in the deal with Thoma Bravo. The period ended Feb. 7, but allowed AMICAS to solicit and negotiate alternative proposals.

Merge intervened in Massachusetts litigation challenging the adequacy of AMICAS’ disclosures relating to this transaction, as well as the process by which its proposals have been considered by the AMICAS Board of Directors.

Merge said it received a signed bridge financing commitment from Morgan Stanley to provide $200 million of debt financing. Based on that commitment and available cash, including $40 million of prefunded equity investments from mezzanine investors, Merge has proposed to commence a $6.05 cash per share tender offer for all AMICAS shares and to close the acquisition as quickly as possible thereafter.

Merge develops solutions that automate healthcare data and diagnostic workflow to enable a better electronic record of the patient experience, and to enhance product development for health IT, device and pharmaceutical companies. Healthcare providers, vendors and researchers use merge products, ranging from standards-based development toolkits to sophisticated clinical applications.

AMICAS is a leading independent provider of imaging IT solutions. It offers image and information management solutions, including radiology PACS, cardiology PACS, radiology information systems, cardiovascular information systems, revenue cycle management solutions and enterprise content management tools designed to power the imaging component of the electronic medical record (EMR).

For more information: www.merge.com, www.amicas.com

Related Content

Healthcare cybersecurity concerns have increased dramatically as EMRs and medical devices become more digitally connected.

Healthcare cybersecurity concerns have increased dramatically as EMRs and medical devices become more digitally connected.

Feature | Cybersecurity| August 18, 2017 | Dave Fornell
August 17, 2017 — Cybersecurity has become a growing concern in healthcare as patient data, medical systems and impla
ScImage Awarded U.S. Government DIN-PACS IV Contract
News | PACS| August 16, 2017
ScImage Inc. was recently awarded a new DIN-PACS IV (Digital Imaging Network/Picture Archiving and Communications...
The Centricity Cardio Enterprise (CCE) Interactive Guide offers information on GE's cardiovascular information system (CVIS)
News | Cardiac PACS| July 28, 2017
July 28, 2017 — GE Healthcare has released the eight-page...
WVU Medicine Deploys Enterprise PACS from ScImage
News | Cardiac PACS| July 24, 2017
ScImage Inc. recently announced West Virginia University Health System has partnered with ScImage to utilize ScImage’s...
Innovative Cardiovascular Ultrasound Solutions Showcased at ASE 28th Annual Scientific Sessions
News | Cardiovascular Ultrasound| June 01, 2017
June 1, 2017 — More than 50 companies and organizations will display their latest products and services at the Americ
Memorial Hospital of Gulfport used a McKesson, Change Healthcare, cardiovascular information system (CVIS) to improve workflow efficiency

Memorial Hospital has increased efficiency using a single cardiovascular information management database. 

Sponsored Content | Case Study | Cardiac PACS| May 23, 2017
Located along Mississippi’s Gulf Coast, Memorial Hospital at Gulfport is a nonprofit, 445-bed facility originally est
News | Information Technology| May 11, 2017
McKesson Imaging & Workflow Solutions, an industry leader in providing healthcare IT and imaging solutions, is...
DASpecialists and Lumedx partner for data abstraction and support services for cardiovascular registries, NCDR, ACC, STS
News | Cardiac PACS| May 05, 2017
May 5, 2017 — DASpecialists LLC, a provider of data abstraction and support services for mandated or voluntary cardio

Physicians will need to use a CMS-certified appropriate use criteria (AUC) clinical decision support software that documents the appropriateness of an imaging order to receive full reimbursement for Medicare patients starting Jan. 1, 2018.

Feature | Cardiac Imaging| April 18, 2017 | Dave Fornell
As part of U.S. healthcare reform efforts, starting Jan.
Sponsored Content | Videos | Analytics Software| April 13, 2017
The shift to value-based payment models requires focused attention on quality and cost.
Overlay Init